You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
Dow
Medtronic

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Oxtriphylline - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for oxtriphylline and what is the scope of patent protection?

Oxtriphylline is the generic ingredient in four branded drugs marketed by Parke Davis, Morton Grove, Watson Labs, and Warner Chilcott Llc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for oxtriphylline.

Summary for oxtriphylline
US Patents:0
Tradenames:4
Applicants:4
NDAs:7
Drug Master File Entries: 3
Bulk Api Vendors: 20
DailyMed Link:oxtriphylline at DailyMed

US Patents and Regulatory Information for oxtriphylline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis CHOLEDYL oxtriphylline TABLET, DELAYED RELEASE;ORAL 009268-007 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis CHOLEDYL oxtriphylline SOLUTION;ORAL 009268-012 Nov 27, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Warner Chilcott Llc CHOLEDYL SA oxtriphylline TABLET, EXTENDED RELEASE;ORAL 087863-001 May 24, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Warner Chilcott Llc CHOLEDYL SA oxtriphylline TABLET, EXTENDED RELEASE;ORAL 086742-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs OXTRIPHYLLINE oxtriphylline TABLET, DELAYED RELEASE;ORAL 087835-001 Aug 25, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Morton Grove OXTRIPHYLLINE PEDIATRIC oxtriphylline SYRUP;ORAL 088242-001 Dec 5, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Parke Davis CHOLEDYL oxtriphylline SYRUP;ORAL 009268-011 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Dow
Moodys
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.